Back the Biotech Company Unlocking Mushroom Health Benefits for All

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

NIO Stock Climbs Higher As Investors Await Key Onvo Launch

Henry Khederian
July 31, 2025

Shares of Chinese electric vehicle manufacturer NIO Inc – ADR (NYSE:NIO) are trading higher Thursday, extending a 40% monthly rally despite a lack of new company-specific news. The upward momentum appears to be driven by continued investor optimism ahead of a key product launch and supported by recently released positive delivery data.

What To Know: The stock has rallied over 40% in the past month, with much of the excitement centered on its new mass-market sub-brand, Onvo. Customer deliveries for the brand’s first vehicle, the L90 SUV, are set to begin on August 1. Analysts, such as Morgan Stanley’s Tim Hsiao, view the Onvo rollout as a significant catalyst, recently reaffirming a Buy rating and a $5.90 price target.

This positive sentiment is bolstered by strong operational results. On July 1, NIO announced it had delivered 24,925 vehicles in June and 72,056 vehicles for the second quarter of 2025, representing year-over-year increases of 17.5% and 25.6%, respectively.

While investors are optimistic, they are also digesting potential headwinds, including recent comments from Chinese President Xi Jinping cautioning against uncoordinated investment in the EV sector. For now, however, the focus remains on NIO's growth trajectory as it prepares to expand its product lineup and challenge competitors like Li Auto and XPeng.

Benzinga Edge Rankings: According to Benzinga Edge stock rankings, NIO presents a mixed profile based on key factor scores. The stock shows moderate strength in Momentum, with a score of 54.61, indicating that its recent price action is somewhat positive.

However, its fundamental metrics appear weaker. The Value score is relatively low at 32.52, suggesting the stock may be considered expensive based on its valuation multiples. Furthermore, the Growth score is notably weak at 13.53, pointing to sluggishness in its historical or projected revenue and earnings expansion.

Price Action: According to data from Benzinga Pro, NIO shares are trading higher by 9.4% to $4.93 during Thursday’s session. The stock has a 52-week high of $7.71 and a 52-week low of $3.02.

Read Also: China Questions Nvidia’s AI Chip As US Export Controls Stoke Tensions

How To Buy NIO Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in NIO’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock

Continue Reading...

Popular

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert

Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Jim Cramer Prefers This Financial Stock Over Brighthouse Financial

Cramer looks at Brighthouse Financial, Hecla Mining, Universal Technical Institute, and Grindr, which all closed lower on Monday.

Trump, Powell Clash Over $3 Billion Federal Reserve Renovations In Front Of Reporters

President Trump and Fed Chair Jerome Powell have a public disagreement on Thursday at the Federal Reserve building.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

New Jersey US Attorney Fired After Being Chosen Over Former Trump Lawyer Alina Habba

The U.S. Attorney for the District of New Jersey, Desiree Leigh Grace, has been dismissed by the Justice Department.

Celestica Stock Surges On Q2 Earnings Beat, Company Raises 2025 Outlook On 'Strengthening' Demand

Celestica announces financial results for the second quarter Monday after the bell. Here's a rundown of the supply chain solutions company's report.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Trump to visit Federal Reserve headquarters as feud with its chair continues

WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?

Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.

Hidden $5 AI Manufacturer Revealed - Ad

The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.

BlackSky Technology Stock Tumbled On Tuesday: What Happened?

BlackSky Technology Inc. (NYSE: BKSY) shares fell nearly 10% on Tuesday after Canaccord Genuity cut its price target on the stock.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Pakistan urges global social media platforms to block accounts run by banned militant groups

ISLAMABAD (AP) — on Friday urged to take action to block hundreds of accounts allegedly run by outlawed militant groups that Islamabad claims spread propaganda and glorify insurgents in the South Asian country.

XPO Cuts Costs, Expands Margins Despite Freight Slowdown

XPO, Inc. (NYSE: XPO) reported Q2 2025 financial results, with adjusted EPS of $1.05 beating analyst consensus. Revenue was $2.08B, slightly above estimates. North American LTL segment showed strong operational performance.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Mark Zuckerberg Wore $99,000 Purple Watch During A Meta Product Launch And This How It Gets Its Vibrant Color

Zuckerberg steals the show at Meta's product launch by wearing a limited edition De Bethune watch worth $99,000. His growing collection includes other high-end brands like Greubel Forsey and Richard Mille.

FOMC Meeting Preview: Will Jerome Powell Accelerate The Bitcoin, Ethereum, XRP Bull Run?

Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Jury orders Tesla to pay more than $200 million in Autopilot crash case

MIAMI (AP) — A Miami jury decided that Elon Musk’s car company Tesla was partly responsible for a deadly crash in Florida involving its Autopilot driver assist technology and must pay the victims more than $200 million in punitive damages.

Meta's AI Firepower Could Ignite Magnificent Seven ETFs

Meta Platformsis expected to report its 11th consecutive revenue beat, attracting attention from stock pickers and ETF investors due to its growing presence in Big Tech and AI-themed ETFs.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Coldplay's jumbotron captures — what exactly? The internet has its theories

LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Sony's Chipset Unit Up For Sale To Fuel Entertainment Push

Sony is selling its cellular chipset unit as it focuses on entertainment. The unit, acquired for $212M in 2016, could be worth $300M.

UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025

UnitedHealth missed Wall Street’s second-quarter earnings expectations and offered an updated, and conservative take on the rest of 2025.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs

On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright traderelite.club
Privacy Policy | Terms of Service